Wholesale 99% Hydroxypropyl Beta Cyclodextrin Hpbcd Hpcd CAS 128446-35-5 Pharmaceutical Excipient Powder

Name: Wholesale 99% Hydroxypropyl Beta Cyclodextrin Hpbcd Hpcd CAS 128446-35-5 Pharmaceutical Excipient Powder
Brand: Xi'an Furuida Biotechnology Co., Ltd.
SKU: 2156049012

Shaanxi, ChinaXi'an Furuida Biotechnology Co., Ltd.

US$30.00-50.00

2 kg

Sample price:US$10.00/kg.Request sample

Product profile

Customization

Available

Powder

Yes

Customized

Non-Customized

Certification

GMP, ISO 9001, Kosher\Halal

Suitable for

Elderly, Adult

State

Solid

Purity

>99%

Shelf Life

2 Years

Production Date

Consult Customer Service

Shipping

Support Deposit

Shipping Time

7-15 Days

Payment Method

Tt\U\Alipay\Worldfirst

Transport Package

Aluminum Foil Bags/Cardboard Drums

Specification

1kg, 5kg, 25kg

Trademark

Furuida

Origin

China

Production Capacity

100000

Company profile

High Repeat Buyers ChoiceLow MOQ100% Finished Products InspectionCustomization from Samples

Xi'an Furuida Biotechnology Co., Ltd.

Shaanxi, China

Business Type: Trading CompanyExport Year: 2021-12-03Nearest Port: shanghai, tianjin, qingdaoAverage Response Time: ≤0.64hTerms of Payment: T/T, Small-amount payment, LC, etc.International Commercial Terms(Incoterms): FOB, CIF, DDP

AI-Powered supplier vetting

SummaryThe supplier operates in diverse sectors including healthcare products, cosmetics, and food sales but lacks overseas infrastructure like agents or warehouses. Financial metrics over recent years indicate no revenue or profit, suggesting financial instability. Their service and quality management processes lack formal documentation, and innovation capabilities are minimal with no ODM or OEM services. Despite having a quality assurance process, their customization and after-sales service capabilities are limited.

Supplier typeThe supplier's business scope includes sales of health care products, cosmetics, food sales, and technical promotion, indicating a focus on diverse sectors.

After-Sales capabilityThere are no written procedures or records for handling customer complaints, indicating a lack of structured after-sales service capability.

Financial creditThe supplier has shown no operating revenue or profit over the last three years, indicating financial instability.

R&D capabilityThe supplier lacks ODM and OEM services and does not have R&D capabilities with SDK availability, indicating limited innovation capability.

Production capacityThe supplier lacks stock and overseas manufacturing capabilities, suggesting limited production capacity.

Customization capabilityWith only one R&D engineer providing samples, the supplier's customization capability is minimal.